Furthermore, our data provide proof‐of‐concept evidence that targeting RBM20 to reduce arterial stiffness through titin isoform switching may benefit aging‐ or hypertension‐associated arterial stiffness and vascular diseases. The gene discussed is TTN; the disease is hypertensive disorder.